Bladder Cancer Molecular Classification: Current Status and Future Prospects.

VALUE OF BIOCHEMICAL URINARY MARKERS IN DIAGNOSIS AND PROGNOSIS OF BLADDER CANCER PATIENTS

Evaluation of Serum Bladder Cancer Specific Nuclear Matrix Proteins - 1 levels in Non-Muscle Invasive Bladder Cancer Patients.

Immunohistochemical expression of matrix metalloproteinase-9 in urothelial carcinoma of urinary bladder

Identification and Characterization of Nuclear Matrix Protein(s) and assessment of its usefullness for early diagnosis of bladder cancer

Expression of matrix metalloproteinase-2 (MMP-2) and tissue inhibitor metalloproteinase-2 (TIMP-2) in patients with bladder cancer versus chronic bilharzial bladder

Prospective clinical study onthe value of nuclear matrixprotein (NMP22) as a urinarytumor marker in the diagnosisand follow up of patients withbladder cancer

Evaluation of nuclear matrix protein 22 (nmp22) as urinary marker for bladder cancer

BLADDER CANCER RECOGNITION: NEW TREND

piRABC and TNFSF4 as biomarkers for diagnosis and staging of bladder cancer.